A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. (17th November 2018)

• Record Type: Journal Article
• Authors: Holmqvist, Fredrik; Kesek, Milos; Englund, Anders; Blomström-Lundqvist, Carina; Karlsson, Lars O; Kennebäck, Göran; Poçi, Dritan; Samo-Ayou, Romeo; Sigurjónsdóttir, Runa; Ringborn, Michael; Herczku, Csaba; Carlson, Jonas; Fengsrud, Espen; Tabrizi, Fariborz; Höglund, Niklas; Lönnerholm, Stefan; Kongstad, Ole; Jönsson, Anders; Insulander, Per
• Is Part Of: European heart journal. Volume 40:Number 10(2019)
• Page Start: 820
• Page End: 830
• Publication Date: 2018-11-17
• Subjects: Catheter ablation -- Adverse events -- Outcome; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehy709
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Aims: Catheter ablation is considered the treatment of choice for many tachyarrhythmias, but convincing 'real-world' data on efficacy and safety are lacking. Using Swedish national registry data, the ablation spectrum, procedural characteristics, as well as ablation efficacy and reported adverse events are reported. Methods and Results: Consecutive patients (≥18 years of age) undergoing catheter ablation in Sweden between 01 January 2006 and 31 December 2015 were included in the study. Follow-up (repeat ablation and vital status) was collected through 31 December 2016. A total of 26 642 patients (57 ± 15 years, 62% men), undergoing a total of 34 428 ablation procedures were included in the study. In total, 4034 accessory pathway/Wolff–Parkinson–White syndrome (12%), 7358 AV-nodal re-entrant tachycardia (21%), 1813 atrial tachycardia (5.2%), 5481 typical atrial flutter (16%), 11 916 atrial fibrillation (AF, 35%), 2415 AV-nodal (7.0%), 581 premature ventricular contraction (PVC, 1.7%), and 964 ventricular tachycardia (VT) ablations (2.8%) were performed. Median follow-up time was 4.7 years (interquartile range 2.7–7.0). The spectrum of treated arrhythmias changed over time, with a gradual increase in AF, VT, and PVC ablation ( P < 0.001). Decreasing procedural times and utilization of fluoroscopy with time, were seen for all arrhythmia types. The rates of repeat ablation differed between ablation types, with the highest repeat ablation seen in AF (41% within 3 years). The rate of reported adverse events was low ( n = 595, 1.7%). Death in the immediate period following ablation was rare ( n = 116, 0.34%). Conclusion: Catheter ablations have shifted towards more complex procedures over the past decade. Fluoroscopy time has markedly decreased and the efficacy of catheter ablation seems to improve for AF.